rapilysin
actavis group ptc ehf - reteplaas - müokardi infarkt - antitrombootilised ained - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.
tygacil
pfizer europe ma eeig - tigecycline - bacterial infections; skin diseases, bacterial; soft tissue infections - antibacterials süsteemseks kasutamiseks, - tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: , complicated skin and soft tissue infections (cssti), excluding diabetic foot infections, complicated intra-abdominal infections (ciai) , tygacil should be used only in situations where other alternative antibiotics are not suitable. tuleks arvesse võtta ametlikke juhiseid sobiva kasutada antibakteriaalseid aineid. vajadusele kasutada antibakteriaalseid aineid.
trecondi
medac gesellschaft für klinische spezialpräparate mbh - treosulfan - hematopoeetiline tüvirakkude siirdamine - antineoplastilised ained - treosulfan in combination with fludarabine is indicated as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (allohsct) in adult patients and in paediatric patients older than one month with malignant and non-malignant diseases.
epirubicin kabi 2 mg/ml süste-/infusioonilahus
fresenius kabi oncology plc - epirubitsiin - süste-/infusioonilahus - 2mg 1ml 5ml 1tk; 2mg 1ml 50ml 1tk
glypressin süstelahus
ferring gmbh - terlipressiin - süstelahus - 0,1mg 1ml 8.5ml 5tk
braunol nahalahus
b. braun melsungen ag - joodpovidoon - nahalahus - 75mg 1g 100ml 1tk; 75mg 1g 1000ml 1tk
epirubicin actavis süstelahus
teva b.v. - epirubitsiin - süstelahus - 2mg 1ml 100ml 1tk; 2mg 1ml 5ml 1tk; 2mg 1ml 25ml 1tk; 2mg 1ml 10ml 1tk
epirubicin ebewe süste-/infusioonilahuse kontsentraat
sandoz pharmaceuticals d.d. - epirubitsiin - süste-/infusioonilahuse kontsentraat - 2mg 1ml 50ml 1tk; 2mg 1ml 100ml 1tk; 2mg 1ml 5ml 1tk
farmorubicin pfs süste-/infusioonilahus
pfizer enterprises sarl - epirubitsiin - süste-/infusioonilahus - 2mg 1ml 5ml 1tk; 2mg 1ml 25ml 1tk
epirubicin accord süste-/infusioonilahus
accord healthcare b.v. - epirubitsiin - süste-/infusioonilahus - 2mg 1ml 50ml 1tk; 2mg 1ml 5ml 1tk; 2mg 1ml 25ml 1tk; 2mg 1ml 10ml 1tk